1. Study design and patient selection
After obtaining the approval of institutional review board (Approval no:
2020/8-2), a retrospective review of the patients who underwent
an intestinal anastomosis during the gyne-oncological surgeries between
September 2017 and March 2021 was performed at an ESGO (European Society
of Gynecological Oncology) accredited center in Turkey (Tepecik
Education and Research Hospital, Izmir). Patients’ hospital files,
pathology and radiology reports, and laboratory results were throughly
reviewed. Exclusion criteria were defined as R2 cancer resection (gross
residual disease) and non-gynecological malignancies according to final
pathology report. Collected data included patient’s age, body mass index
(BMI) (kg/m2), ASA (American Society of
Anesthesiologists) score, type of the malignancy, operative procedure,
patient outcome, and the serum levels of biomarkers taken through the
hospitalization time.